| |
Welcome

About ICE Pharma Group
ICE Pharma Group was founded in 1999 and has helped launch numerous new generics onto the world markets from its offices in the UK.
The management team has high level skills across all necessary functions, gained through experience in acquiring, registering and selling generic products in the UK.
The team has also managed a large number of international manufacturing projects; upgrading quality systems and equipment to achieve cGMP approval. Projects are being undertaken in China, Taiwan, Indonesia, Jordan and Malta.
David Bilton - CEO
30 years experience in global strategic procurement, supply chain management and integrated business development in the healthcare sector. Held a series of senior positions in SmithKline Beecham within the supply, procurement and development functions; latterly joint ventures and outsourcing were a key focus. Biochemist by discipline, member of the Chartered Institute of Purchasing.
Asa Cox - Business Development Director
15 years of generic industry experience, covering international commercial projects in Active Ingredients, Contract Manufacturing, Dossier Development and Licensing. Asa has built the industries largest contact network through Generic Licensing and puts ICE Pharma Group in the position to partner with companies worldwide.
|
SERVICES

Sourcing and negotiating licenses/dossiers deals
Dossier due diligence and updating
Facility GMP inspection preparation
Technical transfer of product to new/trigger facility
Regulatory affairs activities and strategy
Pharmacovigilance and medical reporting
Project and budget management
Contractual requirements and negotiations
Responsibilities of MA holder management
Sales order processing and physical distribution
|